EN
HI
Summary
As of 17 Sep, 2026, Aurobindo Pharma stock price is ₹1690. During the trading session, the stock has moved between an intraday low of ₹1634.00 and an intraday high of ₹1692.30. Over the last 52 weeks, Aurobindo Pharma has traded between ₹1066.80 and ₹1717.00.
The stock has recorded a trading volume of 7,58,827 shares,. Its Average Traded Price (ATP) is ₹1677.97, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 7 @ ₹1690.00.
Aurobindo Pharma has an upper circuit limit of ₹1807.30 and a lower circuit limit of ₹1478.70. The total value traded stands at ₹127.33 CR, and the delivery percentage for the day is 47.58%.
The stock is currently traded with a market lot size of 1. Aurobindo Pharma also offers a dividend yield of 0.24%.
Aurobindo Pharma Share Price Chart
Aurobindo Pharma Share Key Metrics
Volume
7.59 L
Market Cap
97238.86 CR
LTQ@LTP
7@1690.00
ATP
1677.97
Var Margin
14.25 %
Circuit Range
1478.7-1807.3
Delivery %
47.58 %
Value
127.33 CR
ASM/GSM
No
Market Lot
1
Aurobindo Pharma Fundamentals
P/E Ratio
25.43
P/B Ratio
2.43
Div. Yield
0.24
Sector P/E
40.64
Sector P/B
3.51
Sec. Div. Yield
0.51
Aurobindo Pharma Resistance and Support
Pivot 1641.03
Resistance
First Resistance
1659.06
Second Resistance
1675.13
Third Resistance
1693.16
Support
First Support
1624.96
Second Support
1606.93
Third Support
1590.86
Aurobindo Pharma Futures & Options
Aurobindo Pharma Option Chain
View Price, OI, Greeks & More...
29SEP26
1687.20
33.60 (2.03%)
27OCT26
1696.90
34.60 (2.08%)
23NOV26
1702.80
34.80 (2.09%)
AUROPHARMA|29SEP26 CE 1680.00
32.75
11.6 (54.85%)
AUROPHARMA|29SEP26 PE 1700.00
35
-26.8 (-43.37%)
Aurobindo Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Sep 17 2026 | 1634 | 1690 | 2.86% | 1692.3 | 1634 |
| Wed Sep 16 2026 | 1657.09 | 1643 | -1.02% | 1657.09 | 1623 |
| Tue Sep 15 2026 | 1688 | 1660 | -1.18% | 1688 | 1642.09 |
Aurobindo Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-05 | Quarterly Results |
| 2026-05-21 | Audited Results |
| 2026-04-06 | Buy Back of Shares |
| 2026-02-09 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-08-04 | Quarterly Results & Interim Dividend |
| 2025-05-26 | Audited Results |
| 2025-02-06 | Quarterly Results |
| 2024-11-09 | Quarterly Results |
| 2024-08-10 | Quarterly Results |
Aurobindo Pharma News
Aurobindo Pharma Ltd - 524804 - Completion Of US FDA Inspection At Unit-II Of Apitoria Pharma Private Limited, A Wholly Owned Subsidiary Of The Company
Aurobindo Pharma's wholly owned subsidiary, Apitoria Pharma Private Limited, completed a US FDA inspection of its Unit-II API manufacturing facility. The inspection concluded with a single procedural observation, which the company will address.
Sep 15 2026 18:14:22
Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Aurobindo Pharma has received final USFDA approval for Beclomethasone Dipropionate HFA Inhalation Aerosol (40 mcg and 80 mcg). This marks the company's first metered-dose inhaler (MDI) product, strengthening its presence in complex respiratory therapies. The US market for the reference product was $301 million.
Sep 15 2026 13:10:33
Read More
Aurobindo Pharma Management
| Name | Position |
|---|---|
| Mangalam Ramasubramanian Kumar | Chairman |
| K Nityananda Reddy | Vice Chairman & Managing Director |
Aurobindo Pharma Similar Stocks
Cipla Ltd.
1376.30
18.30 (1.35%)
Zydus Lifesciences Ltd.
1135.10
27.60 (2.49%)
Laurus Labs Ltd.
1948.10
42.60 (2.24%)
Max Healthcare Institute Ltd.
1037.00
12.00 (1.17%)
Dr. Reddy's Laboratories Ltd.
1175.00
35.00 (3.07%)
Mankind Pharma Ltd.
2300.00
54.00 (2.40%)
Lupin Ltd.
2098.10
53.10 (2.60%)
Manipal Health Enterprises Ltd.
721.55
6.95 (0.97%)
Glenmark Pharmaceuticals Ltd.
2416.00
6.00 (0.25%)
Fortis Healthcare Ltd.
886.10
15.80 (1.82%)
Aurobindo Pharma FAQs
The Buying Price of Aurobindo Pharma share is 1690 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aurobindo Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aurobindo Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aurobindo Pharma shares is 25.43. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aurobindo Pharma shares is 2.43. Useful to assess the stock's value relative to its book value.
To assess Aurobindo Pharma’s valuation compare Sector P/E, P/B which are 40.64 & 3.51 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aurobindo Pharma is 97238.86 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aurobindo Pharma share price is 1717.00 & 1066.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aurobindo Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in AUROPHARMA
Or Download Choice FinX App
Invest in AUROPHARMA
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade